The relative importance of clinical, economic, patient values and feasibility criteria in cancer drug reimbursement in Canada: A revealed preferences analysis of recommendations of the pan-Canadian Oncology Drug Review 2011–2017

Chris Skedgel, Dominika Wranik, Min Hu

Research output: Contribution to journalArticlepeer-review

33 Citations (Scopus)
8 Downloads (Pure)

Search results